Annual Non Current Assets
$2.99 M
-$1.86 M-38.32%
December 31, 2023
Summary
- As of February 7, 2025, CMPX annual long term assets is $2.99 million, with the most recent change of -$1.86 million (-38.32%) on December 31, 2023.
- During the last 3 years, CMPX annual non current assets has risen by +$1.28 million (+75.19%).
- CMPX annual non current assets is now -54.99% below its all-time high of $6.65 million, reached on December 31, 2021.
Performance
CMPX Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$8.01 M
+$5.95 M+287.94%
September 1, 2024
Summary
- As of February 7, 2025, CMPX quarterly long term assets is $8.01 million, with the most recent change of +$5.95 million (+287.94%) on September 1, 2024.
- Over the past year, CMPX quarterly non current assets has increased by +$5.48 million (+216.52%).
- CMPX quarterly non current assets is now at all-time high.
Performance
CMPX Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
CMPX Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.3% | +216.5% |
| 3 y3 years | +75.2% | +216.5% |
| 5 y5 years | -47.9% | +216.5% |
CMPX Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -55.0% | at low | at high | +287.9% |
| 5 y | 5-year | -55.0% | +75.2% | at high | +368.8% |
| alltime | all time | -55.0% | +75.2% | at high | +368.8% |
Compass Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $8.01 M(+287.9%) |
| Jun 2024 | - | $2.06 M(-18.4%) |
| Mar 2024 | - | $2.53 M(-15.5%) |
| Dec 2023 | $153.88 M(-21.0%) | $2.99 M(-13.3%) |
| Sep 2023 | - | $3.45 M(-11.6%) |
| Jun 2023 | - | $3.91 M(-10.6%) |
| Mar 2023 | - | $4.37 M(-9.9%) |
| Dec 2022 | $194.79 M | $4.85 M(-8.1%) |
| Sep 2022 | - | $5.28 M(-7.5%) |
| Jun 2022 | - | $5.71 M(-9.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $6.28 M(-5.6%) |
| Dec 2021 | $147.10 M(+193.0%) | - |
| Dec 2021 | - | $6.65 M(+5.1%) |
| Sep 2021 | - | $6.33 M(-0.2%) |
| Jun 2021 | - | $6.34 M(-3.3%) |
| Mar 2021 | - | $6.55 M(+283.3%) |
| Dec 2020 | $50.20 M(+91.3%) | $1.71 M(-40.2%) |
| Sep 2020 | - | $2.86 M(-9.6%) |
| Jun 2020 | - | $3.16 M(-23.7%) |
| Dec 2019 | $26.24 M(-55.4%) | $4.14 M |
| Dec 2018 | $58.88 M | - |
FAQ
- What is Compass Therapeutics annual long term assets?
- What is the all time high annual non current assets for Compass Therapeutics?
- What is Compass Therapeutics annual non current assets year-on-year change?
- What is Compass Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Compass Therapeutics?
- What is Compass Therapeutics quarterly non current assets year-on-year change?
What is Compass Therapeutics annual long term assets?
The current annual non current assets of CMPX is $2.99 M
What is the all time high annual non current assets for Compass Therapeutics?
Compass Therapeutics all-time high annual long term assets is $6.65 M
What is Compass Therapeutics annual non current assets year-on-year change?
Over the past year, CMPX annual long term assets has changed by -$1.86 M (-38.32%)
What is Compass Therapeutics quarterly long term assets?
The current quarterly non current assets of CMPX is $8.01 M
What is the all time high quarterly non current assets for Compass Therapeutics?
Compass Therapeutics all-time high quarterly long term assets is $8.01 M
What is Compass Therapeutics quarterly non current assets year-on-year change?
Over the past year, CMPX quarterly long term assets has changed by +$5.48 M (+216.52%)